pharmaceutical – Our Curious Amalgam

Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

#172 Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

Posted 1 year ago Tagged analysis antitrust biologics biosimilars competition economics generics intellectual property law litigation market payment pharmaceutical settlement

Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […]

Can They Really Say That? Product Denigration Under French Antitrust Law

#96 Can They Really Say That? Product Denigration Under French Antitrust Law

Posted 3 years ago Tagged abuse of dominance Article 101 Article 102 French Competition Authority French competition law pharmaceutical product denigration

At its most basic, marketing often consists of simply explaining a product’s qualities relative to […]

Eric Grannon, Partner, White & Case LLP

#75 What’s Coming Next? Understanding the Next Big Areas in the Pharmaceutical Antitrust Wars

Posted 3 years ago Tagged antitrust class action competition drug intellectual property IP litigation patent pharmaceutical price product settlement

Battles in the pharmaceutical antitrust world have been increasingly heated, and to a great extent […]